Bristol-Myers Hepatitis Drug Works - FDA Staff

WASHINGTON (Reuters) - Bristol-Myers Squibb Co.'s. experimental drug to treat chronic hepatitis B infection showed benefits and improved liver problems, U.S. regulatory staff said in documents released on Thursday.

Continue to Bristol-Myers Hepatitis Drug Works - FDA Staff on Reuters: Health.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz